Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether methylphenidate hydrochloride extended
release liquid formulation is safe and effective in the treatment of
attention-deficit/hyperactivity disorder (ADHD) in high-functioning adults with autism
spectrum disorders (ASD).